Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Not yet recruiting 3 Active not recruiting 3 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

pembrolizumab 11 Nivolumab 6 fludarabine phosphate 5 fludarabine 5 Paclitaxel 5 Cyclophosphamide 5 Cisplatin 5 Cetuximab 5 Carboplatin 5 atezolizumab 4 Specimen Handling 4 Pemetrexed 4 Docetaxel 4 Bevacizumab 4 durvalumab 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 venetoclax 2 temsirolimus 2 niraparib 2 ibrutinib 2 enzalutamide 2 encorafenib 2 binimetinib 2 Trastuzumab 2 Taxes 2 Standard of Care 2 Sirolimus 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Mitomycin × 30 days × Clear all

NCT02106572 2026-05-22

TIM

Abnoba Gmbh

Phase 3 Terminated

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡